Cronos Announces Exchange Approval for Cronos Israel and Key Additions to Senior Leadership Team

Cronos Group Inc. (TSX-V: MJN) (OTC – Nasdaq Int'l Designation: PRMCF) ("Cronos" or the "Company") is pleased to announce that its previously announced strategic joint venture ("Cronos Israel") with Kibbutz Gan Shmuel ("Gan Shmuel") for the production, manufacture, and global distribution of medical cannabis, has been approved by the TSX Venture Exchange.  

Cronos Group Secures $40M in Debt for Domestic Capacity Expansion

Cronos Group Inc. (TSXV:MJN) (OTC: PRMCF) is announcing today that it has entered into a commitment letter for $40 million in debt financing with Romspen Investment Corporation to fund the continued construction of its 315,000 sq. ft. expansion previously outlined in the Company's press release dated May 23, 2017.